Developer docs
API playgroundTry for free, no card

Search company profiles

Gaorong Capital

Full company profile

uuid00006ez

Namestring
Gaorong Capital
Legal namestring
高榕创投
Websiteurl
gaorongvc.com
Company typeenum
Private
Founded yearint
2014
Descriptiontext

Gaorong Capital (高榕创投) is a privately-held Chinese venture capital firm founded in January 2014 by three founding partners — Zhang Zhen (张震), Gao Xiang (高翔), and Yue Bin (岳斌) — and headquartered in Beijing with additional offices in Shanghai, Shenzhen, and Hong Kong. The firm self-positions as "China's Founders' Fund" and invests across early (Seed, Series A) and growth (Series B, C+) stages, with thematic focus on new technology (AI infrastructure, humanoid robotics, autonomous driving, semiconductors, quantum computing), internet and new consumption (e-commerce, entertainment, brands, retail, AI applications), and healthcare (digital health, drug development, medical devices). The team has grown from the three founders to approximately 70 professionals, drawing from top-tier Chinese and global universities and prior experience at leading PE/VC firms, internet platforms, and professional services.

The firm raises capital from a diversified LP base that includes charitable foundations, university endowments, fund-of-funds, family offices, and dozens of corporate LPs whose founders and senior executives are drawn from major Chinese internet companies — Tencent, Baidu, Alibaba, Xiaomi, Meituan, Pinduoduo, and Focus Media. Gaorong generates returns through equity investments in portfolio companies, earning carried interest via IPO exits (notably on the Hong Kong Stock Exchange), M&A, and secondary transactions. As of early 2026 the firm reports 300+ portfolio investments and 30+ IPO exits, including Pinduoduo, BOSS Zhipin, Huya, Roborock, Nuro, Different Group/BeBeBus, QuantifyBase, Seyond, and Mingming Henmang. Beyond capital, the firm operates the "Ronghui" (榕汇) innovation community, providing curated knowledge-sharing, networking, and operational support across topics including generative AI, organizational design, globalization, and healthcare commercialization. Gaorong does not develop or sell technology products; its product is portfolio construction, capital, and ecosystem access.

Short descriptiontext

Gaorong Capital is a Chinese venture capital firm, founded in 2014 by Zhang Zhen, Gao Xiang, and Yue Bin, that invests across early and growth stages in new technology, internet and new consumption, and healthcare, serving Chinese and select global startups with capital sourced from institutional and internet-founder LPs.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersWangjing, China
HQ citystring
Wangjing
HQ countrystring
China
HQ regionstring
Asia
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
venture capital investing, early-stage equity investments, growth-stage technology investing, startup funding services, technology sector investments
Industry1 code
1Sector-Focused Venture Capital (Vertical Specialists)
CodeFSANAAADPrimaryYes
NAICS code2 codes
  • All Other Financial Investment Activities52399
  • Other Investment Pools and Funds5259
SIC code1 code
  • Investment Advice6282
Product category
Venture Capital and Private Equity
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Venture Capital Fund Management
TypeLicensing Royalties
Description

Gaorong Capital generates returns through equity investments in early and growth-stage companies. The firm raises capital from limited partners (charitable foundations, university endowments, family offices, corporate giants) and deploys it into portfolio companies, earning returns through IPOs, M&A exits, and secondary market transactions.

gaorongvc.com
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 record
1榕汇
Description

Innovation community launched by Gaorong Capital to build an ecosystem network connecting top entrepreneurs, outstanding founders, industry experts, and opinion leaders.

gaorongvc.com
Core offering1 text field

Gaorong Capital is a venture capital firm that raises capital from limited partners (charitable foundations, university endowments, family offices, internet company founders) and deploys it as equity into early and growth-stage Chinese startups. The firm invests across three verticals: new technology (AI, robotics, autonomous driving, semiconductors, quantum computing, carbon neutrality, aerospace), internet and new consumption (e-commerce, entertainment, brands, retail, AI applications), and healthcare (digital health, drug development, medical devices). It has invested in 300+ companies and achieved 30+ IPO exits.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 300+ portfolio companies invested
+4 more records
Product overview1 text field

Gaorong Capital (高榕创投) is a venture capital firm founded in 2014 by three founding partners: Zhang Zhen, Gao Xiang, and Yue Bin. The firm specializes in early-stage and growth-stage investments across three primary sectors: new technology (including smart hardware, robotics, artificial intelligence, autonomous driving, semiconductors, enterprise services, industrial upgrades, carbon neutrality, aerospace, and quantum computing), internet and new consumption (including new e-commerce, entertainment, brands, retail, and AI applications), and healthcare (including digital health, medical services, drug development, and medical devices). The firm has invested in over 300 companies with 30+ successful IPOs. Their innovation community called '榕汇' (Ronghui) serves as an ecosystem network connecting entrepreneurs, industry experts, and opinion leaders. As a VC firm, Gaorong Capital does not develop or sell technology products.

Product and service1 record
1Ronghui (榕汇) Innovation Community
CategoryVenture Capital Ecosystem and Community Services
Description

An innovation community that provides Gaorong's portfolio companies and external entrepreneurs with curated industry insights, strategy sharing, and networking opportunities across topics including generative AI, organization management, macro strategy, globalization, industry innovation, and healthcare technology. Hosts multiple themed salons (Organization, Strategy, Globalization, Industry Innovation, Healthcare, Generative AI) each year.

Scale indicator19 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Established Chinese growth investor with diversified TMT, healthcare, and consumer portfolio. Comparable check size range at growth stage and overlapping LP base of institutional and corporate investors.

TypeDirect peer
Description

Top-tier Chinese VC with a closely aligned sector focus on TMT and healthcare/biotech, including digital health and medical devices. Comparable stage and check size; co-investor with Gaorong in Pulnovo Medical.

TypeDirect peer
Description

Tech-focused Chinese VC founded by Kai-Fu Lee with strong AI, robotics, and enterprise software concentration. Directly comparable AI-and-deep-tech thesis and stage focus.

TypeDirect peer
Description

Seed-to-Series A Chinese tech investor with similar founder-driven ethos and frequent co-investment alongside Gaorong (e.g., Pollo AI, Archon Robotics). Direct competitor for early-stage deal flow in Beijing and Shanghai.

TypeDirect peer
Description

Active early-stage Chinese internet and technology investor with comparable TMT and consumer mandate. Direct overlap in deal sourcing and stage focus; founder-network-driven culture analogous to Gaorong's.

TypeDirect peer
Description

One of the longest-tenured Chinese VC firms with deep early/growth tech coverage and a similar founder-LP structure. Frequently co-invests with Gaorong (e.g., Taiyi Quantum, Sunrise, Archon Robotics), reflecting directly comparable deal profiles.

TypeDirect peer
Description

Early-stage Chinese tech and consumer investor with comparable TMT focus and similar founder-community approach. Frequently overlaps with Gaorong in pre-seed and seed rounds of Chinese startups.

TypeDirect peer
Description

Former Sequoia China, HongShan is the closest direct peer — a top-tier Chinese tech and growth investor with comparable TMT, consumer, and healthcare focus, similar 300+ portfolio scale, and overlapping LP and founder relationships.

TypeDirect peer
Description

Tech-native Chinese VC with deep enterprise software, consumer internet, and AI coverage. Comparable stage, sector mix, and Chinese founder-network distribution.

TypeDirect peer
Description

Large-scale Chinese investment platform with deep TMT, consumer, and healthcare exposure from early to public stages. Comparable mandate, scale, and cross-border capability; co-investor with Gaorong in XPeng Aeroht and Axoft.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment394 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Gaorong Capital

Venture Capital and Private Equitygaorongvc.com

Gaorong Capital is a Chinese venture capital firm, founded in 2014 by Zhang Zhen, Gao Xiang, and Yue Bin, that invests across early and growth stages in new technology, internet and new consumption, and healthcare, serving Chinese and select global startups with capital sourced from institutional and internet-founder LPs.

What Gaorong Capital does

Gaorong Capital (高榕创投) is a privately-held Chinese venture capital firm founded in January 2014 by three founding partners — Zhang Zhen (张震), Gao Xiang (高翔), and Yue Bin (岳斌) — and headquartered in Beijing with additional offices in Shanghai, Shenzhen, and Hong Kong. The firm self-positions as "China's Founders' Fund" and invests across early (Seed, Series A) and growth (Series B, C+) stages, with thematic focus on new technology (AI infrastructure, humanoid robotics, autonomous driving, semiconductors, quantum computing), internet and new consumption (e-commerce, entertainment, brands, retail, AI applications), and healthcare (digital health, drug development, medical devices). The team has grown from the three founders to approximately 70 professionals, drawing from top-tier Chinese and global universities and prior experience at leading PE/VC firms, internet platforms, and professional services.

The firm raises capital from a diversified LP base that includes charitable foundations, university endowments, fund-of-funds, family offices, and dozens of corporate LPs whose founders and senior executives are drawn from major Chinese internet companies — Tencent, Baidu, Alibaba, Xiaomi, Meituan, Pinduoduo, and Focus Media. Gaorong generates returns through equity investments in portfolio companies, earning carried interest via IPO exits (notably on the Hong Kong Stock Exchange), M&A, and secondary transactions. As of early 2026 the firm reports 300+ portfolio investments and 30+ IPO exits, including Pinduoduo, BOSS Zhipin, Huya, Roborock, Nuro, Different Group/BeBeBus, QuantifyBase, Seyond, and Mingming Henmang. Beyond capital, the firm operates the "Ronghui" (榕汇) innovation community, providing curated knowledge-sharing, networking, and operational support across topics including generative AI, organizational design, globalization, and healthcare commercialization. Gaorong does not develop or sell technology products; its product is portfolio construction, capital, and ecosystem access.

Gaorong Capital firmographics

Firmographics
Name
Gaorong Capital
Legal name
高榕创投
Website
https://gaorongvc.com
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
51–100 employees
Short description
Gaorong Capital is a Chinese venture capital firm, founded in 2014 by Zhang Zhen, Gao Xiang, and Yue Bin, that invests across early and growth stages in new technology, internet and new consumption, and healthcare, serving Chinese and select global startups with capital sourced from institutional and internet-founder LPs.
Ownership category
akta.pro rank

Gaorong Capital industry classification

Industry
Product category
Venture Capital and Private Equity
NAICS
All Other Financial Investment Activities (52399), Other Investment Pools and Funds (5259)
SIC
Investment Advice (6282)
akta.pro primary industry
Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)

Keywords

  • Venture capital investing
  • Early-stage equity investments
  • Growth-stage technology investing
  • Startup funding services
  • Technology sector investments

Where Gaorong Capital is headquartered

Location

Headquarters

HQ city
Wangjing
HQ country
China
HQ region
Asia

Offices4 records

Markets served

Gaorong Capital business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Others

Revenue model

  1. Venture Capital Fund Management: Gaorong Capital generates returns through equity investments in early and growth-stage companies. The firm raises capital from limited partners (charitable foundations, university endowments, family offices, corporate giants) and deploys it into portfolio companies, earning returns through IPOs, M&A exits, and secondary market transactions.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Gaorong Capital product offering

Product offering

Core offering

Gaorong Capital is a venture capital firm that raises capital from limited partners (charitable foundations, university endowments, family offices, internet company founders) and deploys it as equity into early and growth-stage Chinese startups. The firm invests across three verticals: new technology (AI, robotics, autonomous driving, semiconductors, quantum computing, carbon neutrality, aerospace), internet and new consumption (e-commerce, entertainment, brands, retail, AI applications), and healthcare (digital health, drug development, medical devices). It has invested in 300+ companies and achieved 30+ IPO exits.

Product overview

Gaorong Capital (高榕创投) is a venture capital firm founded in 2014 by three founding partners: Zhang Zhen, Gao Xiang, and Yue Bin. The firm specializes in early-stage and growth-stage investments across three primary sectors: new technology (including smart hardware, robotics, artificial intelligence, autonomous driving, semiconductors, enterprise services, industrial upgrades, carbon neutrality, aerospace, and quantum computing), internet and new consumption (including new e-commerce, entertainment, brands, retail, and AI applications), and healthcare (including digital health, medical services, drug development, and medical devices). The firm has invested in over 300 companies with 30+ successful IPOs. Their innovation community called '榕汇' (Ronghui) serves as an ecosystem network connecting entrepreneurs, industry experts, and opinion leaders. As a VC firm, Gaorong Capital does not develop or sell technology products.

Differentiator

Problem solved

Functional benefit

Brands

  • 榕汇: Innovation community launched by Gaorong Capital to build an ecosystem network connecting top entrepreneurs, outstanding founders, industry experts, and opinion leaders.

Products and services

  • Ronghui (榕汇) Innovation Community An innovation community that provides Gaorong's portfolio companies and external entrepreneurs with curated industry insights, strategy sharing, and networking opportunities across topics including generative AI, organization management, macro strategy, globalization, industry innovation, and healthcare technology. Hosts multiple themed salons (Organization, Strategy, Globalization, Industry Innovation, Healthcare, Generative AI) each year.

Quantifiable outcome

  • 300+ portfolio companies invested
  • +4 more outcomes

Companies that use Gaorong Capital

Customer profile

Named customers1 record

Segments4 records

Ideal customer profiles2 records

Gaorong Capital technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Gaorong Capital partnerships and signals

Strategic signal

Scale indicators19 records

Recent moves6 records

Expansion highlights6 records

Gaorong Capital competitors and assessment

Company assessment

Direct peers

  • Legend Capital (君联资本): Established Chinese growth investor with diversified TMT, healthcare, and consumer portfolio. Comparable check size range at growth stage and overlapping LP base of institutional and corporate investors.
  • Qiming Venture Partners (启明创投): Top-tier Chinese VC with a closely aligned sector focus on TMT and healthcare/biotech, including digital health and medical devices. Comparable stage and check size; co-investor with Gaorong in Pulnovo Medical.
  • Innovation Works (创新工场): Tech-focused Chinese VC founded by Kai-Fu Lee with strong AI, robotics, and enterprise software concentration. Directly comparable AI-and-deep-tech thesis and stage focus.
  • ZhenFund (真格基金): Seed-to-Series A Chinese tech investor with similar founder-driven ethos and frequent co-investment alongside Gaorong (e.g., Pollo AI, Archon Robotics). Direct competitor for early-stage deal flow in Beijing and Shanghai.
  • Matrix Partners China (经纬中国): Active early-stage Chinese internet and technology investor with comparable TMT and consumer mandate. Direct overlap in deal sourcing and stage focus; founder-network-driven culture analogous to Gaorong's.
  • IDG Capital: One of the longest-tenured Chinese VC firms with deep early/growth tech coverage and a similar founder-LP structure. Frequently co-invests with Gaorong (e.g., Taiyi Quantum, Sunrise, Archon Robotics), reflecting directly comparable deal profiles.
  • 5Y Capital (五源资本): Early-stage Chinese tech and consumer investor with comparable TMT focus and similar founder-community approach. Frequently overlaps with Gaorong in pre-seed and seed rounds of Chinese startups.
  • HongShan (红杉中国): Former Sequoia China, HongShan is the closest direct peer — a top-tier Chinese tech and growth investor with comparable TMT, consumer, and healthcare focus, similar 300+ portfolio scale, and overlapping LP and founder relationships.
  • Source Code Capital (源码资本): Tech-native Chinese VC with deep enterprise software, consumer internet, and AI coverage. Comparable stage, sector mix, and Chinese founder-network distribution.
  • Hillhouse Investment (高瓴): Large-scale Chinese investment platform with deep TMT, consumer, and healthcare exposure from early to public stages. Comparable mandate, scale, and cross-border capability; co-investor with Gaorong in XPeng Aeroht and Axoft.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Gaorong Capital financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Gaorong Capital leadership team

Management profile

Number of profiles

Profiles5 records

Gaorong Capital funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Gaorong Capital M&A and investment

M&A and investment

M&A

Investments394 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Gaorong Capital

What does Gaorong Capital do?

Gaorong Capital is a venture capital firm that raises capital from limited partners (charitable foundations, university endowments, family offices, internet company founders) and deploys it as equity into early and growth-stage Chinese startups. The firm invests across three verticals: new technology (AI, robotics, autonomous driving, semiconductors, quantum computing, carbon neutrality, aerospace), internet and new consumption (e-commerce, entertainment, brands, retail, AI applications), and healthcare (digital health, drug development, medical devices). It has invested in 300+ companies and achieved 30+ IPO exits.

Is Gaorong Capital a public or private company?

Gaorong Capital is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Gaorong Capital founded?

Gaorong Capital was founded in 2014. It employs 51 to 100 people.

Where is Gaorong Capital based?

Gaorong Capital is headquartered in Wangjing, China, in the Asia region.

How does Gaorong Capital make money?

One revenue line is on record: venture Capital Fund Management.

Who are Gaorong Capital's main competitors?

Direct peers on record are Legend Capital (君联资本), Qiming Venture Partners (启明创投), Innovation Works (创新工场), ZhenFund (真格基金), Matrix Partners China (经纬中国), IDG Capital, 5Y Capital (五源资本), HongShan (红杉中国), Source Code Capital (源码资本) and Hillhouse Investment (高瓴).

Does Gaorong Capital have an API?

No public API is recorded for Gaorong Capital.

What industry is Gaorong Capital in?

Gaorong Capital's product category is Venture Capital and Private Equity. Its primary akta.pro industry code is FSANAAAD, Sector-Focused Venture Capital (Vertical Specialists). Its NAICS code is 52399 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
ChinaventureThe most powerful associate professor at Tsinghua University raised 2.7 billion in 7 months.Naive.AI, founded by Dai Jifeng, released its first open-source model Naive-N0.5-Flash, a 309-billion-parameter coding model. The company raised $400 million in three rounds this year, valuing it at $1.42 billion, with investors including Tencent and Sequoia China.ChinaventureZhang Yiming has created another 10 billion.Anew Labs, spun off from ByteDance, raised $290 million in its first independent financing, valuing it at $1.5 billion. ByteDance retains a 56% stake, and the round is the largest in China's AI pharmaceutical sector this year. The article notes AI drug discovery still faces clinical efficacy challenges.FinSMEsAnew Labs Raises USD290M in Funding at USD1.5 Billion ValuationAnew Labs, a Shanghai AI biotech startup, raised $290M at a $1.5B valuation. The round was co-led by HSG, IDG Capital, GL Ventures, and 5Y Capital. Funds will scale computational biology infrastructure, acquire GPU clusters, and expand research teams.LeiphoneAnew Labs已完成 2.9 亿美元融资,红杉中国、高瓴、IDG、五源、高榕等参与Anew Labs, an AI pharmaceutical company, completed its first independent financing round of $290 million on September 16. The round was led by Sequoia China, IDG Capital, Hillhouse Capital, Wuyuan Capital, and Gaorong Capital, with several domestic pharmaceutical groups as strategic investors. The company was spun off from ByteDance in June.36krAnew Labs has closed a USD 290 million financing round, with HSG and other investors participating in the investment.-36氪Anew Labs, an AI pharmaceutical firm, closed its first independent financing round of $290 million. Investors include HSG, IDG Capital, GL Ventures, 5Y Capital, Gaorong Capital, and domestic pharmaceutical groups. The round follows ByteDance's June spinoff of its AI pharmaceutical business line.PedailyGaoyong Venture Capital's new fund of 3 billion is launched: listed companies are queuing up to invest.Gao Rong Venture Capital launched a new fund with a target subscription of 3.261 billion yuan, led by Junzheng Group's 500 million yuan investment. The fund, managed by Tibet Gao Rong Capital, will invest in emerging domestic industries over seven years. Listed companies are queuing up as LPs, reflecting a trend of industrial capital entering venture funds.SynBioBetaMoonwalk Biosciences Announces $70 Million Series B Financing to Advance Adipose-Targeted RNAi Therapies for Obesity and Cardiometabolic DiseasesMoonwalk Biosciences closed a $70 million Series B financing co-led by Alpha Wave and YK Bioventures. Proceeds will advance its lead obesity candidate MW101 into first-in-human studies in late 2027. The company also plans to expand its pipeline of tissue-targeted siRNA medicines.TechNodeXPeng puts humanoid robot production line into operation as first IRON robot walks off autonomously · TechNodeXPeng announced its automated production line for humanoid robots began operations, with the first IRON robot completing final assembly and walking off autonomously. The line is over 80% automated, and XPeng expects scaled production by end of 2026 and commercial deliveries in 2027. The robot features 76 degrees of freedom and three Turing AI chips.ChinaventureMedical AI investor, currently in Hong Kong to recruit PhDs.Hong Kong university medical AI startups are raising capital, with Brain Science Technology completing over $10 million in angel funding and others like Angxin Bio and Si Ruoning Technology securing seed rounds. Mainland investors are now actively entering Hong Kong, with government funds and industrial capital following, as the region's R&D and mainland manufacturing model expands.Venture Capital Access OnlineMoonwalk Biosciences Announces $70 Million Series B Financing to Advance Adipose-Targeted RNAi Therapies for Obesity and Cardiometabolic DiseasesMoonwalk Biosciences closed a $70 million Series B financing co-led by Alpha Wave and YK Bioventures. Proceeds will advance its lead obesity candidate MW101 into first-in-human studies in late 2027 and expand its adipose-targeted RNAi pipeline.